Seroprevalence of Hepatitis B Virus Surface Antigen (HBsAg) Positivity in KAHS Teaching Hospital, Jumla
Keywords:
Seroprevalence, Rural area, High-risk group, Hepatitis B virus, HBsAg infectionRural areaAbstract
Background: Hepatitis B Virus (HBV) infection is a foremost global health problem. In context to Nepal, the prevalence of HBV infection is found to be low, 0.9% (1.1% in males and 0.5% in females), though high prevalence of ≥8% is shown among the population in the mountainous region by several studies. The epidemiology of HBV infection in the population of Jumla is not well-known. This study aimed to find out the seroprevalence of HBV surface antigen (HBsAg) in patients visiting Karnali Academy of Health Sciences Teaching Hospital (KAHS-TH), Jumla, Nepal.
Methods: The cross-sectional study was conducted in people visiting KAHS-TH, Jumla for testing HBsAg from 1st April 2018 to 31st March 2019. The samples collected were tested for HBsAg by using the Rapid HBsAg test kit. All positive cases were further tested by Chemiluminescence (CLIA) method for HBsAg. The data entry was done in Microsoft Excel. After transferring the data into SPSS version 16, data analysis was done.
Results: In this study, 1704 individuals were screened during the study period, out of which, 53 (3.11%) were HBsAg positive. Among the HBsAg positive cases, 22 (4.34%) were males and 31 (2.58%) were females. The highest prevalence (8.1%) was observed in the age group of 40– 45 years. But the prevalence rate is zero in 0-5 years age group and above 65 years of age.
Conclusion: The HBV infection was higher in Jumla as compared to an overall prevalence of Nepal. Males were more infected than females and the middle age group were at the high-risk group of HBV infection.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/